Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

Don Husereau; Michael Drummond; Stavros Petrou; Dan Greenberg; Josephine Mauskopf; Federico Augustovski; Andrew H. Briggs; David Moher; Elizabeth Loder; Chris Carswell

doi:10.1007/s40273-015-0277-8

Reply to Roberts et al. CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

Don Husereau^*, Michael Drummond, Stavros Petrou, Dan Greenberg, Josephine Mauskopf, Federico Augustovski, Andrew H. Briggs, David Moher, Elizabeth Loder, Chris Carswell

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	535-536
Number of pages	2
Journal	PharmacoEconomics
Volume	33
Issue number	5
Early online date	17 Apr 2015
DOIs	https://doi.org/10.1007/s40273-015-0277-8
Publication status	Published - 28 May 2015

Access to Document

10.1007/s40273-015-0277-8

Cite this

@article{e971f23dc279440d86275dd801f8ee61,

title = "Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration",

author = "Don Husereau and Michael Drummond and Stavros Petrou and Dan Greenberg and Josephine Mauskopf and Federico Augustovski and Briggs, {Andrew H.} and David Moher and Elizabeth Loder and Chris Carswell",

year = "2015",

month = may,

day = "28",

doi = "10.1007/s40273-015-0277-8",

language = "English",

volume = "33",

pages = "535--536",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "5",

}

TY - JOUR

T1 - Reply to Roberts et al.

T2 - CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

AU - Husereau, Don

AU - Drummond, Michael

AU - Petrou, Stavros

AU - Greenberg, Dan

AU - Mauskopf, Josephine

AU - Augustovski, Federico

AU - Briggs, Andrew H.

AU - Moher, David

AU - Loder, Elizabeth

AU - Carswell, Chris

PY - 2015/5/28

Y1 - 2015/5/28

UR - http://www.scopus.com/inward/record.url?scp=84931089174&partnerID=8YFLogxK

U2 - 10.1007/s40273-015-0277-8

DO - 10.1007/s40273-015-0277-8

M3 - Article

C2 - 25893576

AN - SCOPUS:84931089174

SN - 1170-7690

VL - 33

SP - 535

EP - 536

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 5

ER -

Reply to Roberts et al. CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

Access to Document

Other files and links

Cite this